http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103966338-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2014-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103966338-B |
| titleOfInvention | Application method of long no-coding RNA (Lnc RNA (Ribonucleic Acid)) RMST (Rhabdomyosarcoma 2 associated Transcript) |
| abstract | The invention discloses an application method of long no-coding RNA (Lnc RNA (Ribonucleic Acid)) RMST (Rhabdomyosarcoma 2 associated Transcript). The application method is used for preparing a prognosis preparation for glioma patients and particularly used for preparing a kit which is used for predicting the prognosis of the glioma patients by a real-time fluorescent quantitative analysis method. Confirmed by researches, the expression of Lnc RNA RMST in glioma tissue is increased, and the prognosis of the glioma patients with high Lnc RNA RMST expression is poorer than that of the glioma patients with low Lnc RNA RMST expression, so that by applying the expression of Lnc RNA RMST to the prognosis prediction of the glioma patients, a powerful basis for molecular biology can be provided for the prognosis of the glioma patients; the application method has far-reaching clinical significance and generalization performance. |
| priorityDate | 2014-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.